Autolus Therapeutics plc Operating Expenses
Autolus Therapeutics plc (AUTL) reported Operating Expenses of $35.62 million for the 3-month period ending 2019-09-30, per its 6-K filed 2019-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2019-11-07
- Autolus Therapeutics plc operating expenses for the quarter ending 2019-09-30 was $35.62M, a 108.76% increase year-over-year.
- Autolus Therapeutics plc operating expenses for the quarter ending 2019-06-30 was $37.20M, a 125.17% increase year-over-year.
- Autolus Therapeutics plc operating expenses for the quarter ending 2018-12-31 was $25.01M, a 197.14% increase year-over-year.
- Autolus Therapeutics plc operating expenses for the quarter ending 2018-09-30 was $17.06M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2019-09-30 | $35.62M 6-K · filed 2019-11-07 | $72.82M derived: sum of 2 quarters · filed 2019-11-07 | $102.98M 6-K · filed 2019-11-07 | |
| 2019-06-30 | $37.20M 6-K · filed 2019-08-08 | $67.36M 6-K · filed 2019-08-08 | ||
| 2018-12-31 | $25.01M 20-F · filed 2019-02-25 | $42.07M derived: sum of 2 quarters · filed 2019-11-07 | $58.59M derived: sum of 3 quarters · filed 2019-11-07 | |
| 2018-09-30 | $17.06M 6-K · filed 2019-11-07 | $33.59M derived: sum of 2 quarters · filed 2019-11-07 | $49.12M 6-K · filed 2019-11-07 | $57.53M 20-F · filed 2019-02-25 |
| 2018-06-30 | $16.52M 6-K · filed 2019-08-08 | $32.05M 6-K · filed 2019-08-08 | ||
| 2017-12-31 | $8.42M 20-F · filed 2019-02-25 | |||
| 2017-09-30 | $23.42M 20-F · filed 2019-02-25 | |||
| 2016-09-30 | $14.38M 20-F · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 |